Scholarlink

Background <p>Liver cirrhosis represents a growing global public health challenge, with increasing mortality rates and significant morbidity. In Africa, and specifically Rwanda, the burden is exacerbated by a high prevalence of hepatitis B and C infections, limited healthcare infrastructure, and complexity of disease management. The aim of this study was to explore the patterns and clinical outcomes of cirrhosis decompensation among adult cirrhotic patients in two referral hospital in Rwanda.</p> Methods <p>An ambidirectional cohort study was conducted over 18 months across two Rwandan referral hospitals, involving adult cirrhotic patients. The research utilized a comprehensive data collection tool, employing non-probabilistic sampling with retrospective and prospective components. The primary outcome was the causes decompensation and the secondary was in-hospital mortality. Data were analyzed using SPSS version 25, applying descriptive, and inferential statistics to examine the factors associated with decompensation and in-hospital mortality s at 95% confidence level, accepting 0.05 margin of errors.</p> Results <p>The study encompassed 162 cirrhotic patients with a mean age of 55.48 years (± 16.06), predominantly males (63.6%). Hepatitis C emerged as the primary risk factor associated with cirrhosis (45%), followed by hepatitis B (23.5%). Bivariate analysis revealed that the cause of decompensation (<i>p</i> &lt; 0.001), endoscopic screening/therapeutic intervention (<i>p</i> &lt; 0.001), and beta-blockers prophylaxis (<i>p</i> &lt; 0.001) were statistically and significantly associated with patient survival during a hospital stay (p-value trend &lt; 0.001). In multivariate analysis, beta-blocker prophylaxis demonstrated a significant protective effect [aOR: 0.256, 95% CI: 0.095–0.688, <i>p</i> = 0.007].</p> Conclusion <p>This study reveals the critical role of beta-blockers prophylaxis, and specific form of decompensation in cirrhotic patient outcomes. The findings emphasize the need for comprehensive clinical management in cirrhosis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Patterns and outcomes of hepatic decompensation among hospitalized patients with cirrhosis in two referral hospitals in Rwanda

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月6日

查看全文
  • Darlene Lieve Nyenyeri,
  • Emile Sebera,
  • Emile Twagirumukiza,
  • Eric Rutaganda,
  • Eric Iracyahari,
  • Gloria Shumbusho,
  • Janvier Murayire,
  • Dirk J. V. Leeuwen

摘要

Background

Liver cirrhosis represents a growing global public health challenge, with increasing mortality rates and significant morbidity. In Africa, and specifically Rwanda, the burden is exacerbated by a high prevalence of hepatitis B and C infections, limited healthcare infrastructure, and complexity of disease management. The aim of this study was to explore the patterns and clinical outcomes of cirrhosis decompensation among adult cirrhotic patients in two referral hospital in Rwanda.

Methods

An ambidirectional cohort study was conducted over 18 months across two Rwandan referral hospitals, involving adult cirrhotic patients. The research utilized a comprehensive data collection tool, employing non-probabilistic sampling with retrospective and prospective components. The primary outcome was the causes decompensation and the secondary was in-hospital mortality. Data were analyzed using SPSS version 25, applying descriptive, and inferential statistics to examine the factors associated with decompensation and in-hospital mortality s at 95% confidence level, accepting 0.05 margin of errors.

Results

The study encompassed 162 cirrhotic patients with a mean age of 55.48 years (± 16.06), predominantly males (63.6%). Hepatitis C emerged as the primary risk factor associated with cirrhosis (45%), followed by hepatitis B (23.5%). Bivariate analysis revealed that the cause of decompensation (p < 0.001), endoscopic screening/therapeutic intervention (p < 0.001), and beta-blockers prophylaxis (p < 0.001) were statistically and significantly associated with patient survival during a hospital stay (p-value trend < 0.001). In multivariate analysis, beta-blocker prophylaxis demonstrated a significant protective effect [aOR: 0.256, 95% CI: 0.095–0.688, p = 0.007].

Conclusion

This study reveals the critical role of beta-blockers prophylaxis, and specific form of decompensation in cirrhotic patient outcomes. The findings emphasize the need for comprehensive clinical management in cirrhosis.